The Global Calciphylaxis
Treatment Market, by Treatment (Drug Therapy, and Hyperbaric Oxygen
Therapy), by End User (Hospital and Clinics, Homecare, and Ambulatory Centers),
and by Region (North America, Latin America, Europe, Asia Pacific, Middle East,
and Africa) was valued at US$ 1,097.7 million in 2017 and is projected to
exhibit a CAGR of 9.6% over the forecast period (2018 - 2026).
Calciphylaxis is a rare condition
characterized by calcification or the aggregation of calcium in a patient’s
blood vessels and the development of thrombosis. This can lead to the death of
cells in a patient’s skin and fatty tissues, thereby causing death. Diagnosis
of calciphylaxis is symptoms-based and various tests such as skin biopsy, blood
tests, and imaging studies confirm the condition. There is no specific
treatment available for calciphylaxis. Healthcare professionals often focus on
balancing the minerals in the body such as calcium and phosphate that may aid
in treatment of the disease. This can be achieved by changing dialysis regimes,
medications, or considering surgery for parathyroid glands. Major surgical
treatments such as parathyroidectomy are mostly recommended for patients with
known primary hyperparathyroidism. However, surgical debridement to remove
necrotic tissue and healing of healthy tissue is more widely used, however, its
efficacy is debated.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2251
Doctors also focus on pain
control, good nutrition, and excellent ulcer care in case the skin has broken
down. Wound management therapies for calciphylaxis include, nonsurgical wound
cleansing and Hyperbaric Oxygen Therapy (HBOT). HBOT can be considered as a
second line of treatment incase wounds do not improve. Researchers and key
players in the market are focused on finding efficient treatment for
calciphylaxis. According to the Journal of the American Society of Nephrology
2017 study, Vitamin K deficiency can have a role in development of calciphylaxis.
Moreover, according a study published in 2017 by BioMed Central Nephology
Journal, four week supplementation of Vitamin K2 can significantly improve
vascular calcification.
Browse 24 Market Data Tables and
21 Figures spread through 165 Pages and in-depth TOC on "Calciphylaxis
Treatment Market, by Treatment (Drug Therapy, and Hyperbaric Oxygen Therapy),
by End User (Hospital and Clinics, Homecare, and Ambulatory Centers), and by
Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa) - Global Forecast to 2026"
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/calciphylaxis-treatment-market-2251
Key Takeaways of the Global Calciphylaxis
Treatment Market:
The global calciphylaxis
treatment market is expected to witness a CAGR of 9.6% during the forecast
period, owing to increasing cases of calciphylaxis associated with dialysis.
According to the Nephrology Dialysis Transplantation Journal 2017 study, the
German Calciphylaxis Registry recorded calciphylaxis reporting rate of
approximately 30 new cases per year among the dialysis patients between 2006 to
2015
Among region, North America
calciphylaxis treatment market is expected to generate maximum revenue during
the forecast period, owing to increasing demand for kidney transplantation
procedures and rising number of dialysis patients. According to the National
Kidney Foundation, in 2016, around 3,000 patients every month underwent kidney
transplant in the U.S.
Major players operating in the
global calciphylaxis treatment market include, 3M, Amgen Inc., BSN Medical,
ConvaTec Inc., Medtronic Plc., Smith & Nephew Plc., and Laboratoris Sanifit
S.L.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2251
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment